UniQure gets FDA green light to file for Huntington's gene therapy approval
17/06/2026 12:08
UniQure gets FDA green light to file for Huntington's gene therapy approval June 17 (Reuters) - Dutch drugmaker UniQure UQ1.F said on Wednesday the U.S. Food and Drug Administration has agreed that data from a mid-stage study could support an accelerated approval filing for its gene therapy to treat Huntington's disease.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Jonathan Ananda)
Recent news on uniQure
See all newsuniQure tumbles after updated Huntington's disease gene therapy data
UniQure plunges as Huntington's trial data disappoints investors (updated)
uniQure tumbles after updated Huntington's disease gene therapy data
UniQure's Huntington's therapy fails to significantly slow disease progression in trial
uniQure seeks US approval for Huntington's gene therapy after FDA reversal